£595.00

The 2016-2021 Outlook for Anti-Migraine Drugs in Greater China

Econometrics

Price data last checked 15 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£595 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 76 days · 76 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 76 days • 1 price levels

Days at Price

Price Analysis

Most common price: £595 (76 days, 100.0%)

Price range: £595 - £595

Price levels: 1 different prices over 76 days

Description

This econometric study covers the latent demand outlook for anti-migraine drugs across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter referred to as "regions"). Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 1,100 cities in Greater China. For each major city in question, the percent share the city is of the region and of Greater China is reported. Each major city is defined as an area of "economic population", as opposed to the demographic population within a legal geographic boundary. For many cities, the economic population is much larger that the population within the city limits; this is especially true for the cities of the Western regions. For the coastal regions, cities which are close to other major cities or which represent, by themselves, a high percent of the regional population, actual city-level population is closer to the economic population (e.g. in Beijing). Based on this "economic" definition of population, comparative benchmarks allow the reader to quickly gauge a city's marketing and distribution value vis-a-vis others. This exercise is quite useful for persons setting up distribution centers or sales force strategies. Using econometric models which project fundamental economic dynamics within each region and city of influence, latent demand estimates are created for anti-migraine drugs. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or

Product Specifications

Format: paperback
ASIN: B014RZ1EOO
Category: Books > Subjects > Business, Finance & Law > Economics > Econometrics
Domain: Amazon UK
Release Date: 28 August 2015
Listed Since: 02 September 2015

The 2016-2021 Outlook for Anti-Migraine Drugs in Greater China

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

The 2016-2021 Outlook for Anti-Migraine Drugs in the United States

The 2023-2028 Outlook for Anti-Migraine Drugs in India

The 2021-2026 World Outlook for Anti-Migraine Drugs

The 2023-2028 Outlook for Anti-Migraine Drugs in the United States

The 2016-2021 Outlook for Anti-Migraine Drugs in Latin America

The 2016-2021 Outlook for Anti-Migraine Drugs in Asia

The 2016-2021 Outlook for Anti-Migraine Drugs in Europe

The 2016-2021 Outlook for Anti-Migraine Drugs in North America & the Caribbean

The 2011-2016 Outlook for Anti-Migraine Drugs in The Middle East

The 2023-2028 World Outlook for Acute-Treatment Migraine Drugs

The 2016-2021 Outlook for Anti-Migraine Drugs in Oceana

The 2025-2030 World Outlook for Anti-Migraine Drugs

The 2023-2028 Outlook for Anti-Migraine Drugs for US Zip Codes

Management of Migraine Pain: Emerging Opportunities and Challenges

The 2016-2021 Outlook for Online Health and Pharmacy-Related Products in Greater China

Springer - Migraine and Headache Disorders Global Perspective

The 2016-2021 Outlook for Over-The-Counter Health Care Products in Greater China

Academic Press - Interventional Management of Migraines

The 2016-2021 Outlook for Women's Tops in Greater China

The 2026-2031 World Outlook for Pain Management Devices

The 2016-2021 Outlook for Women's Apparel and Accessories in Greater China

The 2016-2021 World Outlook for Over-The-Counter Generic Drugs

Traitements de crise et traitements de fond de la migraine: Aspects pharmacothérapeutiques (Omn.Univ.Europ.)

The 2016-2021 Outlook for Telecom CRM, E-Commerce, and Analytics in Greater China